Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_assertion type Assertion NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_head.
- NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_assertion description "[Carriers of the APOE ?2 SNP had a significantly lower risk of CHD hazard ratio (HR) of 0.63 (95% confidence interval [CI]: 0.42-0.95), as did carriers of the APOC2 SNP rs5127 (HR = 0.72, 95% CI: 0.56-0.93), while carriers of APOC1 SNP rs4803770 had higher risk of CHD (HR = 1.36, 95% CI: 1.04-1.78) compared with noncarriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_provenance.
- NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_assertion evidence source_evidence_literature NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_provenance.
- NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_assertion SIO_000772 20498921 NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_provenance.
- NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_assertion wasDerivedFrom befree-20140225 NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_provenance.
- NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_assertion wasGeneratedBy ECO_0000203 NP700182.RA7eJG2dAtp7uh76KB0gBUf-jQJ0r3oDT3cC-R6ltW0so130_provenance.